Glycated albumin blood test for diabetes monitoring

This study measures “circulating biomarkers” (blood-based signals) in people with type 1 or type 2 diabetes, and in some people without diabetes who test positive for certain diabetes antibodies. The goal is to understand what these blood signals can tell us about diabetes development and progression.

This study tests if using a continuous glucose monitor (a small sensor that checks blood sugar without finger pricks) helps people with type 2 diabetes who are on insulin and have trouble accessing care. It's for patients in the New Orleans area with Medicaid, free care, or no insurance.

This study checks if people with diabetes can safely collect their own blood samples at home for routine check-ups. It aims to make monitoring more convenient.

This study uses a continuous glucose monitor (CGM) and an oral glucose tolerance test (OGTT) to check how well your body controls blood sugar. It is for people who may have early signs of diabetes or are at risk and want to better understand their glucose health.

This study evaluates a new saliva test for measuring 1,5-anhydroglucitol, a marker that may help monitor blood sugar control in people with diabetes. Participants will provide saliva samples to see if this non-invasive test can accurately reflect glucose levels.

This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.